BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

62 related articles for article (PubMed ID: 1839326)

  • 1. Effect of 5-hydroxytryptamine on external carotid nerve activity and its blockade by GR38032F in anesthetized rats.
    Yoshioka M; Ikeda T; Abe M; Togashi H; Saito H
    Res Commun Chem Pathol Pharmacol; 1991 Oct; 74(1):39-45. PubMed ID: 1839326
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of a novel 5-hydroxytryptamine3-antagonist, GR38032F, on the 5-hydroxytryptamine-induced increase in carotid sinus nerve activity in rats.
    Yoshioka M
    J Pharmacol Exp Ther; 1989 Aug; 250(2):637-41. PubMed ID: 2527299
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Ventilatory mechanical analysis of respiratory depression induced by serotonin].
    Goda Y
    Hokkaido Igaku Zasshi; 1993 Jan; 68(1):29-41. PubMed ID: 8444402
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacological characterization of 5-hydroxytryptamine-induced apnea in the rat.
    Yoshioka M; Goda Y; Togashi H; Matsumoto M; Saito H
    J Pharmacol Exp Ther; 1992 Feb; 260(2):917-24. PubMed ID: 1531363
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacological characterization of 5-hydroxytryptamine-induced excitation of afferent cervical vagus nerve in anaesthetized rats.
    Yoshioka M; Ikeda T; Abe M; Togashi H; Minami M; Saito H
    Br J Pharmacol; 1992 Jul; 106(3):544-9. PubMed ID: 1387026
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of 5-hydroxytryptamine on gastric motility and efferent gastric vagus nerve activity in rats.
    Yoshioka M; Ikeda T; Togashi H; Saito Y; Saito H
    Res Commun Chem Pathol Pharmacol; 1990 Oct; 70(1):3-10. PubMed ID: 2263761
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacological characterization of FK1052, a dihydropyridoindole derivative, as a new serotonin 3 and 4 dual receptor antagonist.
    Nagakura Y; Kadowaki M; Tokoro K; Tomoi M; Mori J; Kohsaka M
    J Pharmacol Exp Ther; 1993 May; 265(2):752-8. PubMed ID: 8496821
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacological properties of GR38032F, a novel antagonist at 5-HT3 receptors.
    Butler A; Hill JM; Ireland SJ; Jordan CC; Tyers MB
    Br J Pharmacol; 1988 Jun; 94(2):397-412. PubMed ID: 2969267
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of 5-hydroxytryptamine on glossopharyngeal afferent nerve activity in anesthetized rats.
    Yoshioka M; Ikeda T; Togashi H; Saito H
    Eur J Pharmacol; 1993 Jun; 236(3):491-4. PubMed ID: 8359204
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of ondansetron and ICS 205-930 on radiation-induced hypothermia in rats.
    Kandasamy SB
    Radiat Res; 1997 Jun; 147(6):741-6. PubMed ID: 9189174
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serotonin (5-HT)3 receptor blocking activities of YM060, a novel 4,5,6,7-tetrahydrobenzimidazole derivative, and its enantiomer in anesthetized rats.
    Miyata K; Kamato T; Yamano M; Nishida A; Ito H; Katsuyama Y; Yuki H; Tsutsumi R; Ohta M; Takeda M
    J Pharmacol Exp Ther; 1991 Nov; 259(2):815-9. PubMed ID: 1941629
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Participation of a cholinergic mechanism in 5-hydroxytryptamine (5-HT)3 and 5-HT4 receptor-mediated stimulation of gastric emptying in rats.
    Yamano M; Kamato T; Miyata K
    Arzneimittelforschung; 1997 Nov; 47(11):1242-6. PubMed ID: 9428982
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of 5-hydroxytryptamine3 receptor agonists on phosphoinositides hydrolysis in the rat fronto-cingulate and entorhinal cortices.
    Edwards E; Harkins K; Ashby CR; Wang RY
    J Pharmacol Exp Ther; 1991 Mar; 256(3):1025-32. PubMed ID: 1848625
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of various 5-HT3 receptor antagonists, granisetron, ondansetron, ramosetron and azasetron on serotonin (5-HT) release from the ferret isolated ileum.
    Endo T; Minami M; Kitamura N; Teramoto Y; Ogawa T; Nemoto M; Hamaue N; Hirafuji M; Yasuda E; Blower PR
    Res Commun Mol Pathol Pharmacol; 1999; 104(2):145-55. PubMed ID: 10634307
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The 5-HT3 receptor facilitates at-level mechanical allodynia following spinal cord injury.
    Oatway MA; Chen Y; Weaver LC
    Pain; 2004 Jul; 110(1-2):259-68. PubMed ID: 15275776
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Effect of a muscarinic (M1) receptor agonist on sympathetic nerve activity in rats].
    Saito Y
    Hokkaido Igaku Zasshi; 1993 Mar; 68(2):190-204. PubMed ID: 8509063
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Involvement of 5-HT3 receptors in the initiation of pharyngeal reflex.
    Yoshioka M; Goda Y; Ikeda T; Togashi H; Ushiki T; Saito H
    Am J Physiol; 1994 May; 266(5 Pt 2):R1652-8. PubMed ID: 8203646
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 5-HT activates vagal afferent cell bodies in vivo: role of 5-HT2 and 5-HT3 receptors.
    Lacolley P; Owen JR; Sandock K; Lewis TH; Bates JN; Robertson TP; Lewis SJ
    Neuroscience; 2006 Nov; 143(1):273-87. PubMed ID: 17029799
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modulation by 5-HT1A receptors of the 5-HT2 receptor-mediated tachykinin-induced contraction of the rat trachea in vitro.
    Germonpré PR; Joos GF; Pauwels RA
    Br J Pharmacol; 1998 Apr; 123(8):1571-8. PubMed ID: 9605563
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Release of endogenous dopamine by stimulation of 5-hydroxytryptamine3 receptors in rat striatum.
    Blandina P; Goldfarb J; Craddock-Royal B; Green JP
    J Pharmacol Exp Ther; 1989 Dec; 251(3):803-9. PubMed ID: 2600815
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.